{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:29:53Z","timestamp":1794274193936,"version":"4.9.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R35CA242457"],"award-info":[{"award-number":["R35CA242457"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-67539-1","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T15:46:46Z","timestamp":1766245606000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Genome-scale spatial mapping of the Hodgkin lymphoma microenvironment identifies tumor cell survival factors"],"prefix":"10.1038","volume":"17","author":[{"given":"Vignesh","family":"Shanmugam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neriman","family":"Tokcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8877-5913","authenticated-orcid":false,"given":"Daniel","family":"Chafamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0435-2957","authenticated-orcid":false,"given":"Sean","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Borji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail","family":"Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7805-8523","authenticated-orcid":false,"given":"Naeem","family":"Nadaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saoirse","family":"Hanbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irving","family":"Barrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Cable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8741-1344","authenticated-orcid":false,"given":"Jackson","family":"Weir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orr","family":"Ashenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine","family":"Pinkus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1761-9769","authenticated-orcid":false,"given":"Scott","family":"Rodig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Uhler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2794-5165","authenticated-orcid":false,"given":"Evan","family":"Macosko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3949-6897","authenticated-orcid":false,"given":"Margaret","family":"Shipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Abner","family":"Louissaint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2308-3649","authenticated-orcid":false,"given":"Fei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0113-2403","authenticated-orcid":false,"given":"Todd R.","family":"Golub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,20]]},"reference":[{"key":"67539_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan, D. & Weinberg, R. A. The Hallmarks of Cancer. Cell 100, 57\u201370 (2000).","journal-title":"Cell"},{"key":"67539_CR2","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: The next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"67539_CR3","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/nri931","volume":"2","author":"AR Khaled","year":"2002","unstructured":"Khaled, A. R. & Durum, S. K. Lymphocide: cytokines and the control of lymphoid homeostasis. Nat. Rev. Immunol. 2, 817\u2013830 (2002).","journal-title":"Nat. Rev. Immunol."},{"key":"67539_CR4","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","volume":"378","author":"R Schmitz","year":"2018","unstructured":"Schmitz, R. et al. Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma. N. Engl. J. Med. 378, 1396\u20131407 (2018).","journal-title":"N. Engl. J. Med."},{"key":"67539_CR5","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","volume":"24","author":"B Chapuy","year":"2018","unstructured":"Chapuy, B. et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat. Med. 24, 679\u2013690 (2018).","journal-title":"Nat. Med."},{"key":"67539_CR6","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41375-020-01072-6","volume":"35","author":"T Wen","year":"2021","unstructured":"Wen, T., Wang, J., Shi, Y., Qian, H. & Liu, P. Inhibitors targeting Bruton\u2019s tyrosine kinase in cancers: drug development advances. Leukemia 35, 312\u2013332 (2021).","journal-title":"Leukemia"},{"key":"67539_CR7","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.ccell.2021.10.006","volume":"39","author":"WH Wilson","year":"2021","unstructured":"Wilson, W. H. et al. Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL. Cancer Cell 39, 1643\u20131653.e3 (2021).","journal-title":"Cancer Cell"},{"key":"67539_CR8","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1200\/JCO.18.02403","volume":"37","author":"A Younes","year":"2019","unstructured":"Younes, A. et al. PHOENIX investigators. Randomized phase III trial of ibrutinib and rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in non-germinal center B-cell diffuse large B-cell lymphoma. J. Clin. Oncol. 37, 1285\u20131295 (2019).","journal-title":"J. Clin. Oncol."},{"key":"67539_CR9","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrc3774","volume":"14","author":"DW Scott","year":"2014","unstructured":"Scott, D. W. & Gascoyne, R. D. The tumour microenvironment in B cell lymphomas. Nat. Rev. Cancer 14, 517\u2013534 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"67539_CR10","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio, R. et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia 36, 1720\u20131748 (2022).","journal-title":"Leukemia"},{"key":"67539_CR11","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022015851","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo, E. et al. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood 140, 1229\u20131253 (2022).","journal-title":"Blood"},{"key":"67539_CR12","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.ccell.2021.08.011","volume":"39","author":"CB Steen","year":"2021","unstructured":"Steen, C. B. et al. The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma. Cancer Cell 39, 1422\u20131437.e10 (2021).","journal-title":"Cancer Cell"},{"key":"67539_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41572-020-0189-6","volume":"6","author":"JM Connors","year":"2020","unstructured":"Connors, J. M. et al. Hodgkin lymphoma. Nat. Rev. Dis. Prim. 6, 61 (2020).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"67539_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.hoc.2013.10.007","volume":"28","author":"H Stein","year":"2014","unstructured":"Stein, H. & Diehl, V. First Hodgkin Cell Line L428 and the CD30 Antigen: Their Role for Diagnostic and Treatment of CD30-positive Neoplasms. Hematol. Oncol. Clin. North Am. 28, 1\u201311 (2014).","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"67539_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/ijc.2910170108","volume":"17","author":"L Zech","year":"1976","unstructured":"Zech, L., Haglund, U., Nilsson, K. & Klein, G. Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas. Int. J. Cancer 17, 47\u201356 (1976).","journal-title":"Int. J. Cancer"},{"key":"67539_CR16","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/ijc.2910190412","volume":"19","author":"HS Kaplan","year":"1977","unstructured":"Kaplan, H. S. & Gartner, S. \u201cSternberg-reed\u201d giant cells of Hodgkin\u2019s Disease: cultivation in vitro, heterotransplantation, and characterization as neoplastic macrophages. Int. J. Cancer 19, 511\u2013525 (1977).","journal-title":"Int. J. Cancer"},{"key":"67539_CR17","doi-asserted-by":"publisher","first-page":"4065","DOI":"10.1182\/bloodadvances.2019001012","volume":"3","author":"K Wienand","year":"2019","unstructured":"Wienand, K. et al. Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion. Blood Adv. 3, 4065\u20134080 (2019).","journal-title":"Blood Adv."},{"key":"67539_CR18","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1182\/blood-2014-11-610436","volume":"125","author":"J Reichel","year":"2015","unstructured":"Reichel, J. et al. Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells. Blood 125, 1061\u20131072 (2015).","journal-title":"Blood"},{"key":"67539_CR19","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1158\/2643-3230.BCD-22-0128","volume":"4","author":"F Maura","year":"2023","unstructured":"Maura, F. et al. Molecular evolution of classic Hodgkin lymphoma revealed through whole-genome sequencing of Hodgkin and Reed Sternberg cells. Blood Cancer Discov. 4, 208\u2013227 (2023).","journal-title":"Blood Cancer Discov."},{"key":"67539_CR20","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1158\/2767-9764.CRC-23-0140","volume":"3","author":"F Gomez","year":"2023","unstructured":"Gomez, F. et al. Ultra-deep sequencing reveals the mutational landscape of classical Hodgkin lymphoma. Cancer Res. Commun. 3, 2312\u20132330 (2023).","journal-title":"Cancer Res. Commun."},{"key":"67539_CR21","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1200\/JCO.2016.66.4482","volume":"34","author":"MGM Roemer","year":"2016","unstructured":"Roemer, M. G. M. et al. PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome. J. Clin. Oncol. 34, 2690\u20132697 (2016).","journal-title":"J. Clin. Oncol."},{"key":"67539_CR22","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1182\/blood-2010-05-282780","volume":"116","author":"MR Green","year":"2010","unstructured":"Green, M. R. et al. Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma. Blood 116, 3268\u20133277 (2010).","journal-title":"Blood"},{"key":"67539_CR23","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1182\/blood-2017-03-770719","volume":"130","author":"CD Carey","year":"2017","unstructured":"Carey, C. D. et al. Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma. Blood 130, 2420\u20132430 (2017).","journal-title":"Blood"},{"key":"67539_CR24","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1182\/blood-2019-122535","volume":"134","author":"SS Patel","year":"2019","unstructured":"Patel, S. S. et al. The microenvironmental niche in classic Hodgkin lymphoma is enriched for CTLA-4\u2013positive T cells that are PD-1\u2013negative. Blood 134, 2059\u20132069 (2019).","journal-title":"Blood"},{"key":"67539_CR25","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1158\/2159-8290.CD-19-0680","volume":"10","author":"T Aoki","year":"2020","unstructured":"Aoki, T. et al. Single-cell transcriptome analysis reveals disease-defining t-cell subsets in the tumor microenvironment of classic hodgkin lymphoma. Cancer Discov. 10, 406\u2013421 (2020).","journal-title":"Cancer Discov."},{"key":"67539_CR26","doi-asserted-by":"publisher","unstructured":"Chen, X. et al. T cell states, repertoire and function in classical Hodgkin lymphoma revealed through single-cell analyses. Cancer Immunol. Res. https:\/\/doi.org\/10.1158\/2326-6066.CIR-23-0547 (2024).","DOI":"10.1158\/2326-6066.CIR-23-0547"},{"key":"67539_CR27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2105822118","volume":"118","author":"T Aoki","year":"2021","unstructured":"Aoki, T. et al. Single-cell profiling reveals the importance of CXCL13\/CXCR5 axis biology in lymphocyte-rich classic Hodgkin lymphoma. Proc. Natl. Acad. Sci. USA 118, e2105822118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67539_CR28","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1056\/NEJMoa0905680","volume":"362","author":"C Steidl","year":"2010","unstructured":"Steidl, C. et al. Tumor-Associated Macrophages and Survival in Classic Hodgkin\u2019s Lymphoma. N. Engl. J. Med. 362, 875\u2013885 (2010).","journal-title":"N. Engl. J. Med."},{"key":"67539_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.149","volume":"8","author":"JK de Kanter","year":"2024","unstructured":"de Kanter, J. K. et al. Single-cell RNA sequencing of pediatric Hodgkin lymphoma to study the inhibition of T cell subtypes. HemaSphere 8, e149 (2024).","journal-title":"HemaSphere"},{"key":"67539_CR30","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1126\/science.1254257","volume":"344","author":"AP Patel","year":"2014","unstructured":"Patel, A. P. et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344, 1396\u20131401 (2014).","journal-title":"Science"},{"key":"67539_CR31","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","volume":"178","author":"C Neftel","year":"2019","unstructured":"Neftel, C. et al. An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma. Cell 178, 835\u2013849.e21 (2019).","journal-title":"Cell"},{"key":"67539_CR32","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352, 189\u2013196 (2016).","journal-title":"Science"},{"key":"67539_CR33","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1182\/blood-2012-06-439570","volume":"120","author":"C Steidl","year":"2012","unstructured":"Steidl, C. et al. Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma. Blood 120, 3530\u20133540 (2012).","journal-title":"Blood"},{"key":"67539_CR34","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1172\/JCI95993","volume":"128,","author":"MA Weniger","year":"2018","unstructured":"Weniger, M. A. et al. Human CD30+ B cells represent a unique subset related to Hodgkin lymphoma cells. J. Clin. Invest 128,, 2996\u20133007 (2018).","journal-title":"Clin. Invest"},{"key":"67539_CR35","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","volume":"170","author":"A Tsherniak","year":"2017","unstructured":"Tsherniak, A. et al. Defining a Cancer Dependency Map. Cell 170, 564\u2013576.e16 (2017).","journal-title":"Cell"},{"key":"67539_CR36","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41587-021-00830-w","volume":"40","author":"DM Cable","year":"2022","unstructured":"Cable, D. M. et al. Robust decomposition of cell type mixtures in spatial transcriptomics. Nat. Biotechnol. 40, 517\u2013526 (2022).","journal-title":"Nat. Biotechnol."},{"key":"67539_CR37","doi-asserted-by":"crossref","unstructured":"B\u00fcttner, M., Ostner, J., M\u00fcller, C. L., Theis, F. & Schubert, B. scCODA is a Bayesian model for compositional single-cell data analysis. Nat. Commun. 12, (2021).","DOI":"10.1038\/s41467-021-27150-6"},{"key":"67539_CR38","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.4049\/jimmunol.2000335","volume":"205","author":"M Chesneau","year":"2020","unstructured":"Chesneau, M. et al. Efficient expansion of human granzyme B-expressing B cells with potent regulatory properties. J. Immunol. 205, 2391\u20132401 (2020).","journal-title":"J. Immunol."},{"key":"67539_CR39","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/j.cell.2021.02.027","volume":"184","author":"P Gonzalez-Figueroa","year":"2021","unstructured":"Gonzalez-Figueroa, P. et al. Follicular regulatory T cells produce neuritin to regulate B cells. Cell 184, 1775\u20131789.e19 (2021).","journal-title":"Cell"},{"key":"67539_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54512-7","volume":"15","author":"J Paczkowska","year":"2024","unstructured":"Paczkowska, J. et al. Cancer-specific innate and adaptive immune rewiring drives resistance to PD-1 blockade in classic Hodgkin lymphoma. Nat. Commun. 15, 10740 (2024).","journal-title":"Nat. Commun."},{"key":"67539_CR41","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.immuni.2021.07.007","volume":"54","author":"K Mulder","year":"2021","unstructured":"Mulder, K. et al. Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease. Immunity 54, 1883\u20131900.e5 (2021).","journal-title":"Immunity"},{"key":"67539_CR42","doi-asserted-by":"publisher","first-page":"3730","DOI":"10.1073\/pnas.90.8.3730","volume":"90","author":"J Punnonen","year":"1993","unstructured":"Punnonen, J. et al. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. USA 90, 3730\u20133734 (1993).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67539_CR43","first-page":"250","volume":"97","author":"BF Skinnider","year":"2001","unstructured":"Skinnider, B. F. et al. Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood, J. Am. Soc. Hematol. 97, 250\u2013255 (2001).","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"67539_CR44","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1001\/jamadermatol.2023.0627","volume":"159","author":"AS Paller","year":"2023","unstructured":"Paller, A. S. et al. Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis: The Phase 3 ECZTRA 6 Randomized Clinical Trial. JAMA Dermatol 159, 596\u2013605 (2023).","journal-title":"JAMA Dermatol"},{"key":"67539_CR45","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1056\/NEJMoa2206714","volume":"388","author":"JI Silverberg","year":"2023","unstructured":"Silverberg, J. I. et al. Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis. N. Engl. J. Med. 388, 1080\u20131091 (2023).","journal-title":"N. Engl. J. Med."},{"key":"67539_CR46","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1001\/jamadermatol.2020.0079","volume":"156","author":"E Guttman-Yassky","year":"2020","unstructured":"Guttman-Yassky, E. et al. Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis: A Phase 2b Randomized Clinical Trial. JAMA Dermatol 156, 411\u2013420 (2020).","journal-title":"JAMA Dermatol"},{"key":"67539_CR47","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","volume":"375","author":"EL Simpson","year":"2016","unstructured":"Simpson, E. L. et al. SOLO 1 and SOLO 2 Investigators. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N. Engl. J. Med. 375, 2335\u20132348 (2016).","journal-title":"N. Engl. J. Med."},{"key":"67539_CR48","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1182\/blood-2018-04-843714","volume":"132","author":"FZ Cader","year":"2018","unstructured":"Cader, F. Z. et al. Mass cytometry of Hodgkin lymphoma reveals a CD41 regulatory T-cell\u2013rich and exhausted T-effector microenvironment. Blood 132, 825\u2013836 (2018).","journal-title":"Blood"},{"key":"67539_CR49","first-page":"2343","volume":"141","author":"BJ Stewart","year":"2023","unstructured":"Stewart, B. J. et al. Spatial and molecular profiling of the mononuclear phagocyte network in classic Hodgkin lymphoma. Blood 141, 2343\u20132358 (2023).","journal-title":"Blood"},{"key":"67539_CR50","doi-asserted-by":"publisher","first-page":"100551","DOI":"10.1016\/j.modpat.2024.100551","volume":"37","author":"V Men\u00e9ndez","year":"2024","unstructured":"Men\u00e9ndez, V. et al. Mapping the spatial dynamics of the CD4+ T cell spectrum in classical Hodgkin lymphoma. Mod. Pathol. 37, 100551 (2024).","journal-title":"Mod. Pathol."},{"key":"67539_CR51","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1182\/blood.2020005546","volume":"136","author":"J Veldman","year":"2020","unstructured":"Veldman, J. et al. Rosetting T cells in Hodgkin lymphoma are activated by immunological synapse components HLA class II and CD58. Blood 136, 2437\u20132441 (2020).","journal-title":"Blood"},{"key":"67539_CR52","doi-asserted-by":"publisher","unstructured":"Aoki, T. et al Spatially Resolved Tumor Microenvironment Predicts Treatment Outcomes in Relapsed\/Refractory Hodgkin Lymphoma. J. Clin. Oncol. JCO2301115 https:\/\/doi.org\/10.1200\/JCO.23.01115 (2023).","DOI":"10.1200\/JCO.23.01115"},{"key":"67539_CR53","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1128\/MCB.15.6.3336","volume":"15","author":"FW Quelle","year":"1995","unstructured":"Quelle, F. W. et al. Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis. Mol. Cell. Biol. 15, 3336\u20133343 (1995).","journal-title":"Mol. Cell. Biol."},{"key":"67539_CR54","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/380630a0","volume":"380","author":"K Shimoda","year":"1996","unstructured":"Shimoda, K. et al. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380, 630\u2013633 (1996).","journal-title":"Nature"},{"key":"67539_CR55","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1126\/science.8085155","volume":"265","author":"J Hou","year":"1994","unstructured":"Hou, J. et al. An interleukin-4-induced transcription factor: IL-4 Stat. Science 265, 1701\u20131706 (1994).","journal-title":"Science"},{"key":"67539_CR56","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1084\/jem.189.12.1939","volume":"189","author":"U Kapp","year":"1999","unstructured":"Kapp, U. et al. Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells. J. Exp. Med. 189, 1939\u20131946 (1999).","journal-title":"J. Exp. Med."},{"key":"67539_CR57","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1177\/0394632016644447","volume":"29","author":"S Nakayama","year":"2016","unstructured":"Nakayama, S. et al. Role of mast cells in fibrosis of classical Hodgkin lymphoma. Int. J. Immunopathol. Pharmacol. 29, 603\u2013611 (2016).","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"67539_CR58","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1002\/ijc.28189","volume":"133","author":"A Natoli","year":"2013","unstructured":"Natoli, A. et al. Targeting the IL-4\/IL-13 signaling pathway sensitizes Hodgkin lymphoma cells to chemotherapeutic drugs: IL4\/STAT6 regulate survival of Hodgkin lymphoma. Int. J. Cancer 133, 1945\u20131954 (2013).","journal-title":"Int. J. Cancer"},{"key":"67539_CR59","doi-asserted-by":"publisher","first-page":"4202","DOI":"10.1182\/blood-2010-01-265827","volume":"116","author":"J Stanelle","year":"2010","unstructured":"Stanelle, J., D\u00f6ring, C., Hansmann, M.-L. & K\u00fcppers, R. Mechanisms of aberrant GATA3 expression in classical Hodgkin lymphoma and its consequences for the cytokine profile of Hodgkin and Reed\/Sternberg cells. Blood 116, 4202\u20134211 (2010).","journal-title":"Blood"},{"key":"67539_CR60","doi-asserted-by":"publisher","unstructured":"Alig, S. K. et al. Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling. Nature 1\u20133 https:\/\/doi.org\/10.1038\/s41586-023-06903-x (2023).","DOI":"10.1038\/s41586-023-06903-x"},{"key":"67539_CR61","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1158\/0008-5472.CAN-10-2987","volume":"71","author":"V Raia","year":"2011","unstructured":"Raia, V. et al. Dynamic mathematical modeling of IL13-induced signaling in Hodgkin and primary mediastinal B-cell lymphoma allows prediction of therapeutic targets. Cancer Res 71, 693\u2013704 (2011).","journal-title":"Cancer Res"},{"key":"67539_CR62","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41586-023-06797-9","volume":"625","author":"NM LaMarche","year":"2024","unstructured":"LaMarche, N. M. et al. An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis. Nature 625, 166\u2013174 (2024).","journal-title":"Nature"},{"key":"67539_CR63","doi-asserted-by":"crossref","unstructured":"Stickels, R. et al. Library Generation using Slide-seqV2. (2021).","DOI":"10.17504\/protocols.io.bvv6n69e"},{"key":"67539_CR64","doi-asserted-by":"publisher","unstructured":"Stickels, R. R. et al. Highly sensitive spatial transcriptomics at near-cellular resolution with Slide-seqV2. Nat. Biotechnol. 1\u20137 https:\/\/doi.org\/10.1038\/s41587-020-0739-1.","DOI":"10.1038\/s41587-020-0739-1"},{"key":"67539_CR65","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1038\/s41587-022-01483-z","volume":"40","author":"S He","year":"2022","unstructured":"He, S. et al. High-plex imaging of RNA and proteins at subcellular resolution in fixed tissue by spatial molecular imaging. Nat. Biotechnol. 40, 1794\u20131806 (2022).","journal-title":"Nat. Biotechnol."},{"key":"67539_CR66","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jmoldx.2011.08.002","volume":"14","author":"F Wang","year":"2012","unstructured":"Wang, F. et al. RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. J. Mol. Diagn. 14, 22\u201329 (2012).","journal-title":"J. Mol. Diagn."},{"key":"67539_CR67","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.jmoldx.2022.06.002","volume":"24","author":"J Song","year":"2022","unstructured":"Song, J., Kim, J. Y., Kim, S. & Park, Y. Utility of Epstein-Barr viral load in blood for diagnosing and predicting prognosis of lymphoma: A comparison with Epstein-Barr virus-encoded RNA in situ hybridization. J. Mol. Diagn. 24, 977\u2013991 (2022).","journal-title":"J. Mol. Diagn."},{"key":"67539_CR68","doi-asserted-by":"publisher","unstructured":"Shanmugam, V. et al Identification of diverse activating mutations of the RAS-MAPK pathway in histiocytic sarcoma. Mod. Pathol. 1 https:\/\/doi.org\/10.1038\/s41379-018-0200-x (2019).","DOI":"10.1038\/s41379-018-0200-x"},{"key":"67539_CR69","doi-asserted-by":"publisher","first-page":"D1365","DOI":"10.1093\/nar\/gkaa882","volume":"49","author":"L Dwane","year":"2021","unstructured":"Dwane, L. et al. Project Score database: a resource for investigating cancer cell dependencies and prioritizing therapeutic targets. Nucleic Acids Res 49, D1365\u2013D1372 (2021).","journal-title":"Nucleic Acids Res"},{"key":"67539_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02540-7","volume":"22","author":"JM Dempster","year":"2021","unstructured":"Dempster, J. M. et al. Chronos: a cell population dynamics model of CRISPR experiments that improves inference of gene fitness effects. Genome Biol. 22, 343 (2021).","journal-title":"Genome Biol."},{"key":"67539_CR71","doi-asserted-by":"publisher","unstructured":"Dempster, J. M. et al. Extracting biological insights from the project Achilles genome-scale CRISPR screens in cancer cell lines. bioRxiv 720243 https:\/\/doi.org\/10.1101\/720243 (2019).","DOI":"10.1101\/720243"},{"key":"67539_CR72","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s41592-020-0905-x","volume":"17","author":"B Li","year":"2020","unstructured":"Li, B. et al. Cumulus provides cloud-based data analysis for large-scale single-cell and single-nucleus RNA-seq. Nat. Methods 17, 793\u2013798 (2020).","journal-title":"Nat. Methods"},{"key":"67539_CR73","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/s41592-023-01943-7","volume":"20","author":"SJ Fleming","year":"2023","unstructured":"Fleming, S. J. et al. Unsupervised removal of systematic background noise from droplet-based single-cell experiments using CellBender. Nat. Methods 20, 1323\u20131335 (2023).","journal-title":"Nat. Methods"},{"key":"67539_CR74","doi-asserted-by":"publisher","first-page":"979","DOI":"10.12688\/f1000research.73600.1","volume":"10","author":"P-L Germain","year":"2021","unstructured":"Germain, P.-L., Lun, A., Garcia Meixide, C., Macnair, W. & Robinson, M. D. Doublet identification in single-cell sequencing data using scDblFinder. F1000Res 10, 979 (2021).","journal-title":"F1000Res"},{"key":"67539_CR75","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"67539_CR76","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran, D. et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat. Immunol. 20, 163\u2013172 (2019).","journal-title":"Nat. Immunol."},{"key":"67539_CR77","doi-asserted-by":"publisher","first-page":"eabl5197","DOI":"10.1126\/science.abl5197","volume":"376","author":"C Dom\u00ednguez Conde","year":"2022","unstructured":"Dom\u00ednguez Conde, C. et al. Cross-tissue immune cell analysis reveals tissue-specific features in humans. Science 376, eabl5197 (2022).","journal-title":"Science"},{"key":"67539_CR78","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587.e29 (2021).","journal-title":"Cell"},{"key":"67539_CR79","unstructured":"Tickle, T., Georgescu, C., Brown, M. & Haas, B. inferCNV of the Trinity CTAT Project. 2019. Klarman Cell Observatory, Broad Institute of MIT."},{"key":"67539_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19894-4","volume":"11","author":"HL Crowell","year":"2020","unstructured":"Crowell, H. L. et al. Muscat detects subpopulation-specific state transitions from multi-sample multi-condition single-cell transcriptomics data. Nat. Commun. 11, 6077 (2020).","journal-title":"Nat. Commun."},{"key":"67539_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-024-05886-4","volume":"25","author":"D Chafamo","year":"2024","unstructured":"Chafamo, D., Shanmugam, V. & Tokcan, N. C-ziptf: stable tensor factorization for zero-inflated multi-dimensional genomics data. BMC Bioinforma. 25, 323 (2024).","journal-title":"BMC Bioinforma."},{"key":"67539_CR82","doi-asserted-by":"publisher","first-page":"D939","DOI":"10.1093\/nar\/gkaa980","volume":"49","author":"S Tweedie","year":"2021","unstructured":"Tweedie, S. et al. Genenames.org: The HGNC and VGNC resources in 2021. Nucleic Acids Res. 49, D939\u2013D946 (2021).","journal-title":"Nucleic Acids Res."},{"key":"67539_CR83","doi-asserted-by":"publisher","first-page":"btac757","DOI":"10.1093\/bioinformatics\/btac757","volume":"39","author":"Z Fang","year":"2023","unstructured":"Fang, Z., Liu, X. & Peltz, G. GSEApy: a comprehensive package for performing gene set enrichment analysis in Python. Bioinformatics 39, btac757 (2023).","journal-title":"Bioinformatics"},{"key":"67539_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30755-0","volume":"13","author":"D Dimitrov","year":"2022","unstructured":"Dimitrov, D. et al. Comparison of methods and resources for cell-cell communication inference from single-cell RNA-Seq data. Nat. Commun. 13, 3224 (2022).","journal-title":"Nat. Commun."},{"key":"67539_CR85","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/nmeth.4077","volume":"13","author":"D T\u00fcrei","year":"2016","unstructured":"T\u00fcrei, D., Korcsm\u00e1ros, T. & Saez-Rodriguez, J. OmniPath: guidelines and gateway for literature-curated signaling pathway resources. Nat. Methods 13, 966\u2013967 (2016).","journal-title":"Nat. Methods"},{"key":"67539_CR86","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1093\/nar\/gkaa183","volume":"48","author":"S Cabello-Aguilar","year":"2020","unstructured":"Cabello-Aguilar, S. et al. SingleCellSignalR: inference of intercellular networks from single-cell transcriptomics. Nucleic Acids Res. 48, e55 (2020).","journal-title":"Nucleic Acids Res."},{"key":"67539_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18873-z","volume":"11","author":"R Hou","year":"2020","unstructured":"Hou, R., Denisenko, E., Ong, H. T., Ramilowski, J. A. & Forrest, A. R. R. Predicting cell-to-cell communication networks using NATMI. Nat. Commun. 11, 5011 (2020).","journal-title":"Nat. Commun."},{"key":"67539_CR88","doi-asserted-by":"publisher","unstructured":"Cable, D. M. et al. Robust decomposition of cell type mixtures in spatial transcriptomics. bioRxiv 2020.05.07.082750 https:\/\/doi.org\/10.1101\/2020.05.07.082750 (2020).","DOI":"10.1101\/2020.05.07.082750"},{"key":"67539_CR89","doi-asserted-by":"publisher","unstructured":"Cable, D. M. et al. Cell type-specific inference of differential expression in spatial transcriptomics. bioRxiv 2021.12.26.474183 https:\/\/doi.org\/10.1101\/2021.12.26.474183 (2022).","DOI":"10.1101\/2021.12.26.474183"},{"key":"67539_CR90","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1038\/s41592-022-01663-4","volume":"19","author":"M Pachitariu","year":"2022","unstructured":"Pachitariu, M. & Stringer, C. Cellpose 2.0: how to train your own model. Nat. Methods 19, 1634\u20131641 (2022).","journal-title":"Nat. Methods"},{"key":"67539_CR91","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41592-020-01018-x","volume":"18","author":"C Stringer","year":"2021","unstructured":"Stringer, C., Wang, T., Michaelos, M. & Pachitariu, M. Cellpose: a generalist algorithm for cellular segmentation. Nat. Methods 18, 100\u2013106 (2021).","journal-title":"Nat. Methods"},{"key":"67539_CR92","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41592-021-01358-2","volume":"19","author":"G Palla","year":"2022","unstructured":"Palla, G. et al. Squidpy: a scalable framework for spatial omics analysis. Nat. Methods 19, 171\u2013178 (2022).","journal-title":"Nat. Methods"},{"key":"67539_CR93","doi-asserted-by":"publisher","unstructured":"DepMap, B. DepMap 22Q2 Public. https:\/\/doi.org\/10.6084\/M9.FIGSHARE.19700056.V2 (2022).","DOI":"10.6084\/M9.FIGSHARE.19700056.V2"},{"key":"67539_CR94","doi-asserted-by":"publisher","unstructured":"Chafamo, D., Shanmugam, V. & Tokcan, N. Genome-scale spatial mapping of the Hodgkin lymphoma microenvironment identifies tumor cell survival factors vigneshshanmug\/chl_analysis: CHL manuscript analysis. (Zenodo, 2025). https:\/\/doi.org\/10.5281\/ZENODO.17094525.","DOI":"10.5281\/ZENODO.17094525"}],"updated-by":[{"DOI":"10.1038\/s41467-026-73753-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000}}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67539-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67539-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67539-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T07:02:40Z","timestamp":1780124560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67539-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,20]]},"references-count":94,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["67539"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-67539-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.01.24.631210","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,20]]},"assertion":[{"value":"28 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41467-026-73753-2","URL":"https:\/\/doi.org\/10.1038\/s41467-026-73753-2","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.J.R. receives research support from Bristol Myers Squibb, Coherus, and KITE\/Gilead. He is a member of the Scientific Advisory Board of Immunitas Therapeutics. F.C. is an academic founder of Curio Biosciences and Doppler Biosciences and a scientific advisor for Amber Bio. F.C.\u2018s interests were reviewed and managed by the Broad Institute per its conflict-of-interest policies. E.Z.M. is a founder of Curio Bioscience, Inc. M.A.S. has received research funding from Bristol Myers Squibb, AstraZeneca, Bayer, AbbVie, Genentech, and Novartis, and has served on advisory boards for Bristol Myers Squibb and AstraZeneca. T.R.G. is a paid advisor and\/or equity holder in Dewpoint Therapeutics, Sherlock Biosciences, Amplifyer Bio, and Braidwell, Inc. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"838"}}